About Optomed
Optomed is a publicly listed company based in Alpharetta (United States) founded in 2004 by Seppo Kopsala. Provider of handheld fundus cameras and software solutions for eye screening. Optomed has raised $4.92 million across 5 funding rounds from investors including European Union, Mawell and EIC Fund. The company has 115 employees. Optomed has completed 1 acquisition, including Commit. Its chief executive, as recorded, is Seppo Kopsala. Optomed offers products and services including Aurora AEYE, Optomed Aurora IQ, Smartscope PRO, and Optomed Polaris. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Imaging. Its legal entity is Optomed Plc. Its competitors include Eyenuk, LKC Technologies and AEYE Health; 1 of its 3 listed competitors has raised funding.
Company details
Optomed was founded in 2004 and is headquartered in Alpharetta, United States. Handheld fundus cameras integrated with software and artificial intelligence are developed for screening and diagnosing blinding eye diseases, including diabetic retinopathy and macular edema. Operations focus on medical imaging devices within the healthcare sector, targeting improvements in eye care diagnostics through portable technology.
- Annual Revenue$20.09 M (USD)13.67as on Dec 31, 2025
- Net Profit-$7.8 M (USD)-21.83as on Dec 31, 2025
- EBITDA-$5.58 M (USD)-0.91as on Dec 31, 2025
- Total Equity Funding$4.92M (USD)
in 5 rounds
- Latest Funding Round$2.2M (USD), Grant
Jul 2019
- InvestorsEuropean Union
& 6 more
- Employee Count115
- Investments & Acquisitions
Products & Services of Optomed
Optomed offers a comprehensive portfolio of products and services, including Aurora AEYE, Optomed Aurora IQ, Smartscope PRO, and Optomed Polaris.
AI-enabled camera for instant diabetic retinopathy detection.
Fundus camera for eye screening in various settings.
Device for professional ophthalmic examinations.
Stationary fundus camera for detailed eye diagnostics.
Apps and channels of Optomed
its YouTube channel Optomed has 34 subscribers and 30 videos.
Videos from Optomed
The most watched videos on Optomed's YouTube channel, Optomed (34 subscribers). Click a video to play it here.
More on Optomed.
Funding Insights of Optomed
Optomed has successfully raised a total of $4.92M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $2.2 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.92M
- Total Rounds 5
- Last Round Grant — $2.2M
- Investors Count 7
All 5 funding rounds of Optomed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
7 investors in total: 7 institutional.
Investors in Optomed
Optomed has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Mawell and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Venture capital firm investing in tech startups | bosch.ventures | Gerlingen, Germany | ||
| cenovaventures.com | ||||
Private equity investment firm | tesi.fi | Helsinki, Finland | ||
| auratum.com | ||||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Hospital management solutions are offered to healthcare providers. | 2001 | mawell.com | Oulu, Finland |
Investor details for Optomed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Optomed
12 people are tracked at Optomed (7 in leadership, 5 in team); the tracked headcount is 115.
| Name | Role | Group |
|---|---|---|
Seppo Kopsala | Founder & CEO | Leadership |
Ville Pitkänen | Sales Director | Leadership |
Marika Ekroos | Director Quality & Regulatory, DPO | Leadership |
Juuso Erixon | Sales Director | Avenue Flow | Leadership |
Laura Piila | Vice President Devices | Leadership |
Sakari Knuutti | Chief Financial Officer | Leadership |
Juho Himberg | Chief Executive Officer | Leadership |
Arto Peura | Sales Manager | Team |
Tessa Sipilä | Marketing & Business Development Lead | Team |
Kyle Brandt | Product Manager | Team |
Henna Karvonen | Q&ra Specialist | Team |
Michael Weichert | Regional Sales Manager, EMEA | Team |
Complete people profiles for Optomed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Optomed
Optomed is a publicly listed company on the OMXHEX with ticker symbol OPTOMED in Finland, operating in the Electronic technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Dec 2019
- Listed onATHEX: OPTOMED
- Listed entityOptomed Oyj Class A
- Exchange sectorElectronic technology
- ISINFI4000410881
- Share price1.40 EUR (-0.99% on the day) · 2026-10-14
- Market capitalisation29,655,041.00 EUR
- EPS (diluted, trailing year)-0.27 EUR
- Volume (last session)1,270
Financials of Optomed
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 17.1M EUR | -6.6M EUR | -4.8M EUR |
| 2024 | 15.0M EUR | -5.5M EUR | -4.7M EUR |
| 2023 | 15.1M EUR | -4.4M EUR | -2.8M EUR |
| 2022 | 14.7M EUR | -5.5M EUR | -3.7M EUR |
| 2021 | 14.8M EUR | -4.2M EUR | -3.8M EUR |
Detailed financial statements for Optomed
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Optomed
Optomed has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Commit.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Healthcare solutions are provided by Commit in Finland. | commit.fi | Tampere, Finland | 1989 | Mar 2018 | •••• |
Complete acquisition details for Optomed
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Optomed
5 dated milestones of Optomed across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Optomed is founded.
- Funding First funding round.
- Acquisition Acquires Commit.
- Funding Latest funding round, Grant, of $2.2M.
- IPO Lists on the stock exchange (IPO).
Competitors of Optomed
Optomed has 3 listed competitors in our database, 1 of them funded. They include Eyenuk, LKC Technologies and AEYE Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| eyenuk.com | 2010 | Los Angeles, United States | $38.05M | AI-driven retinal image analysis for diabetic retinopathy detection is developed. | ||
| lkc.com | 1976 | Gaithersburg, United States | 35 | Non-mydriatic hand-held devices for visual electrophysiology testing are developed. | ||
| aeyehealth.com | 2018 | New York, United States | AI-based retinal imaging software is provided for eye diagnosis. |
Detailed competitors of Optomed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Optomed
The website of Optomed (optomed.com) receives about 9.2K visits a month.
- Monthly visits9.2K
▲ 17.8% vs previous month
Websites whose visitors overlap most with Optomed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| centervue.com | 100% | View details | |||
dfv.com.au | dfv.com.au | 100% | #5,515,244 | – | |
eyesite.co.za | eyesite.co.za | 100% | – | ||
nidek.com | nidek.com | 99% | #919,019 | – | |
topcon-medical.eu | topcon-medical.eu | 99% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Optomed
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diabetes
3 companies that operate in the same segment as Optomed (Diabetes) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Optomed
Complete news archive for Optomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Optomed
Optomed was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Optomed is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
Seppo Kopsala is the CEO of Optomed, as recorded in our data. They have also founded this company.
Optomed is a funded company, having raised a total of $4.92M across 5 funding rounds to date.
Optomed has 115 employees.
Annual revenue of Optomed is $20.09M as on Dec 31, 2025.
Optomed was founded in 2004 and is headquartered in Alpharetta, United States. Handheld fundus cameras integrated with software and artificial intelligence are developed for screening and diagnosing blinding eye diseases, including diabetic retinopathy and macular edema. Operations focus on medical imaging devices within the healthcare sector, targeting improvements in eye care diagnostics through portable technology.
Optomed's top competitors include Eyenuk, AEYE Health and LKC Technologies.
Optomed offers Aurora AEYE, Optomed Aurora IQ, Smartscope PRO, and Optomed Polaris.
Yes, Optomed is publicly traded on OMXHEX under the ticker symbol OPTOMED.
Optomed has made 1 acquisition, including Commit.
Optomed has 7 investors. Key investors include European Union, Mawell, EIC Fund, Robert Bosch Venture Capital, and Cenova.